Literature DB >> 34306356

Efficacy of autologous bone marrow derived Mesenchymal stem cells (MSCs), osteoblasts and osteoblasts derived exosome in the reversal of ovariectomy (OVX) induced osteoporosis in rabbit model.

Mir Sadat-Ali1,2, Dakheel A Al-Dakheel1,2, Haifa A Al-Turki1,3, Sadananda Acharya4.   

Abstract

Background: A recent study showed that OVX-induced osteoporosis was reversed after injection of osteoblasts cultured from the bone marrow in rats. The present study evaluated the effect of injecting MSCs, osteoblasts, and exosomes isolated from osteoblasts for the treatment of osteoporosis in the rabbit model.
Methods: Osteoporosis was created in 40 rabbits by performing ovareictomy at 6 months of age, and 1 mg/kg body weight of methyl prednisolone sodium succinate was injected daily for 8 weeks. Animals were fed twice daily and were given water ad libitum. MSCs and osteoblasts were grown from the bone marrow as per the methodology described earlier. From osteoblasts, exosomes were extracted. After the 15th day, MSCs (Group 2), osteoblasts (Group 3), and exosomes (Group 4) were injected into 5 animals each, and 0.5 ml of normal saline were injected into the control group (Group 1). After 12 weeks (11 months of age), all the animals were euthanized. The whole femur and the lumbar vertebrae 3-5 were dissected out and were subjected to radiological assessment using high-resolution peripheral quantitative computerized tomography (HRpQCT). All parameters of the bone volume, trabecular number, thickness, and spacing were assessed using SPSS (Statistical Package for the Social Sciences), version 21.0, Chicago, Illinois. A p value of <0.05 was considered Statistically significant with a confidence interval (CI) of 95%.
Results: Structural indices of the osteoblasts-injected animals were significantly better than the control group for the distal femur. The most significant improvement was seen in the osteoblasts, MSCs, and exosomes group in that order. The p value of all parameters was <0.0001 in the osteoblasts group, whereas the total and bone volume had a lower p value in the MSCs group. In the osteoblasts group, the positive changes were similar in the distal femur and lumbar vertebrae, but with MSCs and exosomes, the changes were more pronounced in the vertebral spine than the distal femur. Conclusions: This study shows that autologous bone marrow-derived osteoblasts have the robust influence of reversing OVX-induced osteoporosis in rabbits. AJTR
Copyright © 2021.

Entities:  

Keywords:  Osteoporosis; exosomes; mesenchymal stem cells (MSCs); osteoblasts

Year:  2021        PMID: 34306356      PMCID: PMC8290779     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  31 in total

Review 1.  Post-menopausal osteoporosis.

Authors:  Robert Marcus
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2002-06       Impact factor: 5.237

2.  Compliance with osteoporosis drug therapy and risk of fracture.

Authors:  D Weycker; D Macarios; J Edelsberg; G Oster
Journal:  Osteoporos Int       Date:  2006-10-05       Impact factor: 4.507

3.  Skeletal changes in the ovariectomised ewe and subsequent response to treatment with 17 beta oestradiol.

Authors:  S B Hornby; S L Ford; C A Mase; G P Evans
Journal:  Bone       Date:  1995-10       Impact factor: 4.398

4.  Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws.

Authors:  Daniel Holzinger; Rudolf Seemann; Nadja Matoni; Rolf Ewers; Werner Millesi; Arno Wutzl
Journal:  J Oral Maxillofac Surg       Date:  2014-05-24       Impact factor: 1.895

5.  Intra-bone marrow injection of mesenchymal stem cells improves the femur bone mass of osteoporotic female rats.

Authors:  Natália de Melo Ocarino; Jankerle Neves Boeloni; Vanda Jorgetti; Dawidson Assis Gomes; Alfredo Miranda Goes; Rogéria Serakides
Journal:  Connect Tissue Res       Date:  2010-04-07       Impact factor: 3.417

6.  Bone mineral density among postmenopausal Saudi women.

Authors:  Mir Sadat-Ali; Ibrahim M Al-Habdan; Fatma A Al-Mulhim; Abdallah Y El-Hassan
Journal:  Saudi Med J       Date:  2004-11       Impact factor: 1.484

7.  FDA Guidelines and animal models for osteoporosis.

Authors:  D D Thompson; H A Simmons; C M Pirie; H Z Ke
Journal:  Bone       Date:  1995-10       Impact factor: 4.398

Review 8.  A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ).

Authors:  Katia Rupel; Giulia Ottaviani; Margherita Gobbo; Luca Contardo; Giancarlo Tirelli; Paolo Vescovi; Roberto Di Lenarda; Matteo Biasotto
Journal:  Oral Oncol       Date:  2014-09-17       Impact factor: 5.337

Review 9.  Esophagitis associated with the use of alendronate.

Authors:  P C de Groen; D F Lubbe; L J Hirsch; A Daifotis; W Stephenson; D Freedholm; S Pryor-Tillotson; M J Seleznick; H Pinkas; K K Wang
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

Review 10.  What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.

Authors:  David Y Graham
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

View more
  1 in total

Review 1.  Research Progress of Exosomes in Bone Diseases: Mechanism, Diagnosis and Therapy.

Authors:  Fanying Meng; Xu Xue; Zhifeng Yin; Fei Gao; Xiuhui Wang; Zhen Geng
Journal:  Front Bioeng Biotechnol       Date:  2022-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.